924 related articles for article (PubMed ID: 29906595)
1. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.
Maurer FP; Pohle P; Kernbach M; Sievert D; Hillemann D; Rupp J; Hombach M; Kranzer K
Clin Microbiol Infect; 2019 Mar; 25(3):379.e1-379.e7. PubMed ID: 29906595
[TBL] [Abstract][Full Text] [Related]
2. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T;
Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
[TBL] [Abstract][Full Text] [Related]
3. Difference in drug susceptibility distribution and clinical characteristics between
Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
[No Abstract] [Full Text] [Related]
4. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
5. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.
Hombach M; Somoskövi A; Hömke R; Ritter C; Böttger EC
Int J Med Microbiol; 2013 Jul; 303(5):270-6. PubMed ID: 23689069
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial susceptibility and genotyping of
Wang SQ; Jiang GL; Wei GM; Huo FM; Dong LL; Zhao LP; Huang HR; Wang GR
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jul; 41(7):539-543. PubMed ID: 29996350
[No Abstract] [Full Text] [Related]
7. Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
Li Y; Liu C; Ma A; He W; Qiu Q; Zhao Y; Li Y
J Glob Antimicrob Resist; 2022 Dec; 31():90-97. PubMed ID: 35660663
[TBL] [Abstract][Full Text] [Related]
8. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.
Schön T; Chryssanthou E
Int J Infect Dis; 2017 Feb; 55():122-124. PubMed ID: 28069470
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Huang CC; Wu MF; Chen HC; Huang WC
J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
[TBL] [Abstract][Full Text] [Related]
10. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A
J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192
[TBL] [Abstract][Full Text] [Related]
12. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
[TBL] [Abstract][Full Text] [Related]
13. Drug susceptibility distributions of
Schulthess B; Schäfle D; Kälin N; Widmer T; Sander P
Antimicrob Agents Chemother; 2023 May; 65(5):. PubMed ID: 33619057
[TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
Brown-Elliott BA; Iakhiaeva E; Griffith DE; Woods GL; Stout JE; Wolfe CR; Turenne CY; Wallace RJ
J Clin Microbiol; 2013 Oct; 51(10):3389-94. PubMed ID: 23946523
[TBL] [Abstract][Full Text] [Related]
16. Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles.
Truden S; Žolnir-Dovč M; Sodja E; Starčič Erjavec M
Infect Genet Evol; 2020 Aug; 82():104311. PubMed ID: 32247868
[TBL] [Abstract][Full Text] [Related]
17. Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility.
Chang CL; Chen LC; Yu CJ; Hsueh PR; Chien JY
Int J Infect Dis; 2020 Sep; 98():33-40. PubMed ID: 32534139
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.
Mok S; Hannan MM; Nölke L; Stapleton P; O'Sullivan N; Murphy P; McLaughlin AM; McNamara E; Fitzgibbon MM; Rogers TR
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262760
[No Abstract] [Full Text] [Related]
19. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
[TBL] [Abstract][Full Text] [Related]
20. Differences in Drug-Susceptibility Patterns between
Fernandez-Pittol M; Batista-Arnau S; Román A; San Nicolás L; Oliver L; González-Moreno O; Martínez JA; Amaro-Rodríguez R; Soler N; Gené A; González-Cuevas A; Tudó G; Gonzalez-Martin J
Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
